PROCEPT BioRobotics Corp (PRCT) Financial Statements (2026 and earlier)

Company Profile

Business Address 150 BAYTECH DRIVE
SAN JOSE, CA 95134
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments286,503333,725257,222221,859304,320
Cash and cash equivalent286,503333,725257,222221,859304,320
Restricted cash and investments3,0383,0383,0383,815777
Receivables83,53383,49648,37615,2724,464
Inventory, net of allowances, customer advances and progress billings70,69456,16839,75628,54313,147
Inventory70,69456,16839,75628,54313,147
Prepaid expense     2,984
Other undisclosed current assets6,6105,4152,1753,137481
Total current assets:450,378481,842350,567272,626326,173
Noncurrent Assets
Operating lease, right-of-use asset17,53818,94120,24123,4813,279
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization30,39926,70928,7488,6565,045
Intangible asset, including goodwill, after accumulated amortization, including:7099321,2041,4771,750
Intangible asset, excluding goodwill, after accumulated amortization (1,800)(1,600)(1,300)(1,000)(800)
Other undisclosed intangible asset, including goodwill, after accumulated amortization2,5092,5322,5042,4772,550
Restricted cash and investments3,0383,0383,0383,038777
Other noncurrent assets6,0192,55591951 
Total noncurrent assets:57,70352,17554,15036,70310,851
TOTAL ASSETS:508,081534,017404,717309,329337,024
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities40,46031,56930,38422,8388,504
Employee-related liabilities✕✕✕✕✕6,475
Accounts payable17,28510,03213,4999,3912,029
Accrued liabilities23,17521,53716,88513,447 
Deferred revenue13,0489,5655,6562,8551,025
Derivative instruments and hedges, liabilities  2,0001,886  
Other liabilities10,0738,0896,3187,4684,608
Other undisclosed current liabilities2,2141,9101,6832,1292,105
Total current liabilities:65,79553,13345,92735,29016,242
Noncurrent Liabilities
Long-term debt and lease obligation51,61551,47251,33951,21351,995
Long-term debt, excluding current maturities51,61551,47251,33951,21350,004
Liabilities, other than long-term debt24,80127,19226,69925,7541,696
Other liabilities147324517 200
Operating lease, liability24,65426,86826,18223,9751,991
Derivative instruments and hedges, liabilities    1,7791,496
Total noncurrent liabilities:76,41678,66478,03876,96753,691
Total liabilities:142,211131,797123,965112,25769,933
Equity
Equity, attributable to parent365,870402,220280,752197,072267,091
Additional paid in capital1,007,390948,091735,240545,753528,666
Accumulated other comprehensive income (loss)3711484(6)(54)
Accumulated deficit(641,557)(545,985)(454,572)(348,675)(261,521)
Total equity:365,870402,220280,752197,072267,091
TOTAL LIABILITIES AND EQUITY:508,081534,017404,717309,329337,024

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Revenues308,054224,498136,19175,01434,473
Cost of revenue(111,828)(87,399)(65,142)(37,929)(18,608)
Gross profit:196,226137,09971,04937,08515,865
Operating expenses(300,085)(233,713)(180,219)(117,809)(70,029)
Operating loss:(103,859)(96,614)(109,170)(80,724)(54,164)
Nonoperating income 12,0639,3857,2682,01157
Investment income, nonoperating 12,21910,7817,4442,214211
Other nonoperating expense (156)(1,396)(176)(203)(154)
Interest and debt expense(3,586)(4,184)(3,995)(8,441)(5,810)
Other undisclosed income from continuing operations before equity method investments, income taxes     
Loss from continuing operations before equity method investments, income taxes:(95,382)(91,413)(105,897)(87,154)(59,917)
Other undisclosed income from continuing operations before income taxes     
Loss from continuing operations before income taxes:(95,382)(91,413)(105,897)(87,154)(59,917)
Income tax expense (benefit)(190)    
Other undisclosed loss from continuing operations     
Loss from continuing operations:(95,572)(91,413)(105,897)(87,154)(59,917)
Loss before gain (loss) on sale of properties:✕✕✕✕✕(59,917)
Net loss:(95,572)(91,413)(105,897)(87,154)(59,917)
Other undisclosed net income (loss) attributable to parent    64
Net loss available to common stockholders, diluted:(95,572)(91,413)(105,897)(87,154)(59,853)

Comprehensive Income ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Net loss:(95,572)(91,413)(105,897)(87,154)(59,917)
Comprehensive loss:(95,572)(91,413)(105,897)(87,154)(59,917)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(77)30904824
Comprehensive loss, net of tax, attributable to parent:(95,649)(91,383)(105,807)(87,106)(59,893)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: